Unavailable Treatments

Unfortunately, treatments and over-the-counter products occasionally become unavailable for a variety of reasons.

See below for updates on the unavailable treatments that we are aware of, but please do get in touch with us if you become aware of an issue that is not listed below. We are not always contacted by treatment manufacturers when there is an availability concern, and so we do rely on the information of our supporters.

Silkis Ointment

Following recent availability issues with the vitamin D-based topical treatment, Silkis Ointment (calcitriol), we contacted its manufacturer, Galderma (U.K.) Ltd, for an update in mid-August.

Galderma advised that pharmacies will be able to order stock of Silkis Ointment from 24th August onwards, once the product has been delivered to wholesalers.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01923 208 950, or by email at info.uk@galderma.com.

Ceanel Shampoo

Back in 2018 we reported that the medicated scalp shampoo, Ceanel Concentrate, was out of production as its manufacturer at the time, Alliance Pharmaceuticals, was unable to source the raw materials required for its manufacture. The product has remained unavailable since.

In August 2020 we were made aware that Ceanel Shampoo had been acquired by Derma UK. We have since spoken to Derma UK who advised us that Ceanel Shampoo currently remains unavailable, however they are working tirelessly to bring the product back to market.

In the meantime, we would recommend that anyone affected by the unavailability of Ceanel Shampoo discusses suitable alternatives with their GP or Pharmacist.

If you would like more information about scalp psoriasis and its different available treatment options, please do get in touch with us.

If you have any questions or would like further information, Derma UK can be contacted directly either by phone on 0191 375 9020, or by email at info@dermauk.co.uk.

Clarelux Foam

In January 2020 we reported an update from Pierre Fabre Dermo-Cosmetique, manufacturer of the topical corticosteroid treatment, Clarelux foam, stating that the product's return had been delayed once again and they did not know when it would return to stock.

We have since contacted Pierre Fabre for a further update and they told us that, unfortunately, Clarelux foam will not be available before the end of 2020. They do hope that the product will return to stock in 2021, but are unable to provide a specific date for its return at this time.

If you have any questions or would like further information, Pierre Fabre can be contacted directly either by phone on 0118 334 8003, or by email at medicalinformation@pierre-fabre.co.uk.

Calmurid Cream

In January 2020 we contacted Galderma, the manufacturer of the urea and lactic acid based cream, Calmurid, regarding issues with its availability.

Galderma confirmed that Calmurid has been discontinued, and their medical information team offered the following statement:

'I can confirm that due to a number of reasons wholly beyond our control and after careful consideration of all possible options, a company decision at global level has been taken to discontinue all strengths of Calmurid.

One ingredient of Calmurid (DEA (diethanolamine) and Cocamide DEA) has triggered a safety concern via the regulatory authorities. As safety is our primary priority, Calmurid will not be further produced.

We apologise most sincerely for any inconvenience caused by this and thank you for your understanding.'

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01923 208 950, or by email at info.uk@galderma.com.

Aquamol Emollient Cream

In July 2019 we learned that Thornton and Ross Ltd had announced the withdrawal of Aquamol Emollient Cream from manufacture due to poor demand for the product.

They told the Psoriasis Association 'the minimum volumes that we have to produce on a production run are far higher than demand and as such it wasn't viable to continue producing the product'.

If anyone has any questions, or would like to know more you can get in touch with the manufacturer directly either by phone on 01484 848 164, or by email at thorntonross@medinformation.co.uk

We advise anyone affected by the discontinuation of Aquamol Emollient Cream to speak to their GP about alternative emollients that are available.

Dovobet Gel Applicator

Dovobet Gel Applicator (website news) 1In Jun 2019, LEO Pharma announced plans to phase out its Dovobet Gel (calcipotriol/betamethasone dipropionate gel) applicator from the beginning of summer 2019 in the UK, and autumn 2019 in Ireland. This decision was taken due to a lack of demand for the applicator. Please note that Dovobet Gel remains available in bottles.

LEO apologised for any inconvenience caused by this product discontinuation, and recommended that anybody affected visits their healthcare professional to discuss their individual needs and preferences for the management of their psoriasis.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01844 347 333, or by email at medical-info.uk@leo-pharma.com if you are in the UK.

If you are based in Ireland, you can reach LEO Pharma's Medical Information team either by phone on +353 1 490 89, or by email at medical-info.ie@leo-pharma.com.

The Psoriasis Association is the UK's leading national charity and membership organisation for people affected by psoriasis – patients, families, carers and health professionals Read More >

Get in touch

The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF

Email: mail@psoriasis-association.org.uk

Tel :
01604 251 620
WhatsApp :
07387716439
Registered with Fundraising Regulator -

© The Psoriasis Association Charitable Incorporated Organisation Number: 1180666 Scotland: SC049563 Privacy PolicyCookies

Site by Spoken Image | glitterfish

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you.

If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them.